(Q77334619)

English

Nonpeptide glycoprotein IIB/IIIA inhibitors. 19. A new design paradigm employing linearly minimized, centrally constrained, exosite inhibitors

scientific article published on 01 March 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10206551%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Nonpeptide glycoprotein IIB/IIIA inhibitors. 19. A new design paradigm employing linearly minimized, centrally constrained, exosite inhibitors (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10206551%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

G D Hartman

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10206551%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

M E Duggan

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10206551%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

W F Hoffman

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10206551%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

R J Meissner

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10206551%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

J J Perkins

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10206551%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

A E Zartman

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10206551%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

A M Naylor-Olsen

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10206551%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

J J Cook

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10206551%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

J D Glass

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10206551%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

R J Lynch

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10206551%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

G Zhang

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10206551%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

R J Gould

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10206551%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 March 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10206551%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Bioorganic & Medicinal Chemistry Letters

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10206551%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10206551%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10206551%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

863-868

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10206551%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclic RGD peptide analogues as antiplatelet antithrombotics

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Potent non-peptide fibrinogen receptor antagonists which present an alternative pharmacophore

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

From peptide to non-peptide. 3. Atropisomeric GPIIbIIIa antagonists containing the 3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Investigation of conformational specificity at GPIIb/IIIa: evaluation of conformationally constrained RGD peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-peptide RGD surrogates which mimic a Gly-Asp beta-turn: potent antagonists of platelet glycoprotein IIb-IIIa

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of conformationally restricted benzamidines as arginine surrogates in the design of platelet GPIIb-IIIa receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

New orally active non-peptide fibrinogen receptor (GpIIb-IIIa) antagonists: identification of ethyl 3-[N-[4-[4-[amino[(ethoxycarbonyl) imino]methyl]phenyl]-1,3-thiazol-2-yl]-N-[1-[(ethoxycarbonyl)methyl]pip erid -4-yl]amino]propionate (SR 121787) as

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Design of a new class of orally active fibrinogen receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

GPIIb/IIIa integrin antagonists with the new conformational restriction unit, trisubstituted beta-amino acid derivatives, and a substituted benzamidine structure.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-peptide glycoprotein IIb/IIIa antagonists. 11. Design and in vivo evaluation of 3,4-dihydro-1 (1H)-isoquinolinone-based antagonists and ethyl ester prodrugs

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification and characterization of cell-substratum adhesion receptors on cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900104-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0960-894X(99)00104-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10206551%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10206551%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77334619&oldid=2222676429"